CorEvitas
23
7
8
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
4.3%
1 terminated/withdrawn out of 23 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Alzheimer's Registry
Role: lead
CorEvitas Multiple Sclerosis (MS) Registry
Role: lead
The CorEvitas Psoriasis (PSO) Registry
Role: lead
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
Role: lead
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Role: lead
Rheumatology Biorepository
Role: lead
The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry
Role: lead
CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
Role: lead
CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)
Role: lead
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Role: lead
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Role: lead
CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
Role: lead
PAtient-CenTric Chronic Pancreatitis Registry (PACT-CP)
Role: lead
PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
Role: lead
CorEvitas Inflammatory Bowel Disease (IBD) Registry
Role: lead
CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
Role: lead
CorEvitas Japan Rheumatoid Arthritis (RA) Registry
Role: lead
IBD Pregnancy Registry
Role: lead
Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)
Role: lead
RSV Vaccine Pregnancy Registry
Role: lead